ArticleJournal of public health management and practice : JPHMP
Evaluation of an Asthma Home Visiting Program in the State of Illinois, 2020-2023.
Article in Journal of public health management and practice : JPHMP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
contextAsthma Home Visiting (HV) programs offer community-based education and environmental interventions to improve asthma control and reduce health care use.
objectiveTo evaluate the health, quality of life (QoL), and cost outcomes of a multi-site asthma HV program implemented across Illinois from 2020 to 2023.
designCross-sectional program evaluation using pre- and post- intervention comparisons of health outcomes and health care utilization data.
settingFour Illinois-based HV programs supported by the Illinois Department of Public Health and funded by the Centers for Disease Control and Prevention.
participantsA total of 209 participants (58.4% children) with physician-diagnosed asthma who received HV services between 2020 and 2023.
main outcome measuresChanges in emergency department (ED) visits, hospitalizations, QoL indicators (Asthma Control Rating, ACT scores, and missed school/workdays), and program cost-benefit ratio.
resultsED visits declined from 17.8% to 6% ( P < .05), and hospitalizations from 7.6% to 0% ( P < .05). QoL indicators improved significantly, with ACT well-controlled scores increasing from 24.8% to 45.4%. Estimated annual savings totaled $1.4 million, exceeding program costs of $1.04 million (benefit-cost ratio = 1.34).
conclusionsThe Illinois asthma HV program improved health outcomes and reduced health care utilization, supporting its inclusion in comprehensive asthma care strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.